{"id":"https://openalex.org/W2395946667","doi":null,"title":"Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects.","display_name":"Pharmacokinetics of mexiletine and its metabolites, hydroxymethylmexiletine and p-hydroxymexiletine, after single oral administration in healthy subjects.","publication_year":1990,"publication_date":"1990-07-01","ids":{"openalex":"https://openalex.org/W2395946667","mag":"2395946667","pmid":"https://pubmed.ncbi.nlm.nih.gov/2097598"},"language":"en","primary_location":{"id":"pmid:2097598","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2097598","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"D Paczkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114383","display_name":"Children's Memorial Health Institute","ror":"https://ror.org/020atbp69","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210114383"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"D Paczkowski","raw_affiliation_strings":["Department of Diagnostics Laboratory, Memorial Hospital-Child Health Centre, Warszawa, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diagnostics Laboratory, Memorial Hospital-Child Health Centre, Warszawa, Poland","institution_ids":["https://openalex.org/I4210114383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005133989","display_name":"Z Sadowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z Sadowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016197501","display_name":"Marian Filipek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Filipek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018215340","display_name":"P Koli\u0144ski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Koli\u0144ski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3131,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.56251523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"42","issue":"4","first_page":"365","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mexiletine","display_name":"mexiletine","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7369999885559082},{"id":"https://openalex.org/keywords/metabolic-ratio","display_name":"metabolic ratio","score":0.765999972820282},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.7509999871253967},{"id":"https://openalex.org/keywords/double-peak-phenomenon","display_name":"double peak phenomenon","score":0.5960000157356262},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.7419999837875366},{"id":"https://openalex.org/keywords/serum-clearance","display_name":"serum clearance","score":0.8140000104904175},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9359999895095825},{"id":"https://openalex.org/keywords/mean-residence-time","display_name":"mean residence time","score":0.8349999785423279},{"id":"https://openalex.org/keywords/antiarrhythmic-drugs","display_name":"antiarrhythmic drugs","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C2777561782","wikidata":"https://www.wikidata.org/wiki/Q420377","display_name":"Mexiletine","level":2,"score":0.9785192012786865},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8314098119735718},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7438358068466187},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6517149209976196},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5307210683822632},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5202633142471313},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.4504092037677765},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4324060380458832},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4291726052761078},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29232537746429443}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008801","descriptor_name":"Mexiletine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008801","descriptor_name":"Mexiletine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008801","descriptor_name":"Mexiletine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008801","descriptor_name":"Mexiletine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2097598","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2097598","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Polish journal of pharmacology and pharmacy","raw_type":"Journal Article"},{"id":"mag:2395946667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2097598","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2401471011","https://openalex.org/W2035268874","https://openalex.org/W2138049592","https://openalex.org/W621080604","https://openalex.org/W2053056023","https://openalex.org/W2343240605","https://openalex.org/W2426038039","https://openalex.org/W2087626804","https://openalex.org/W2063278804","https://openalex.org/W2000191638"],"abstract_inverted_index":{"Pharmacokinetics":[0],"of":[1,18,82,127],"mexiletine":[2,49,77,112],"and":[3,8,31,41,59,69,106,113,130],"its":[4,114],"major":[5],"metabolites,":[6],"p-hydroxymexiletine":[7,60],"hydroxymethylmexiletine,":[9],"were":[10,78,98],"studied":[11],"in":[12,102],"10":[13],"healthy":[14],"subjects":[15,123],"after":[16,66],"administration":[17],"a":[19],"single":[20],"oral":[21],"400":[22],"mg":[23],"dose.":[24],"Mexiletine":[25],"was":[26,39,118],"extensively":[27],"metabolized":[28],"to":[29,33],"hydroxymethylmexiletine":[30,54,129],"less":[32],"p-hydroxymexiletine.":[34,131],"Mean":[35],"metabolic":[36],"ratio":[37],"(Rm)":[38],"0.54":[40],"0.18":[42],"respectively.":[43],"Peak":[44],"serum":[45,90],"concentrations":[46],"(Cmax)":[47],"for":[48,76,111,120],"(0.686":[50],"+/-":[51,56,62,71,87,94],"0.110":[52],"micrograms/ml),":[53,58],"(0.507":[55],"0.087":[57],"(0.096":[61],"0.046":[63],"micrograms/ml)":[64],"occurred":[65],"3.0,":[67],"4.0":[68],"4.2":[70],"0.6":[72],"h.":[73],"Disposition":[74],"parameters":[75],"as":[79],"follows:":[80],"volume":[81],"distribution":[83],"(V":[84],"lambda),":[85],"5.44":[86],"1.44":[88],"l/kg;":[89],"clearance":[91],"(CL)":[92],"8.08":[93],"1.23":[95],"ml/min/kg.":[96],"There":[97],"no":[99],"significant":[100],"differences":[101],"elimination":[103,125],"half-life":[104],"(t1/2)":[105],"mean":[107],"residence":[108],"time":[109],"(MRT)":[110],"metabolites.":[115],"Double-peak":[116],"phenomenon":[117],"observed":[119],"all":[121],"the":[122],"on":[124],"phase":[126],"mexiletine,":[128]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}